Skip to Content

Protech Home Medical reports ‘robust’ financial results

Protech Home Medical reports ‘robust’ financial results

CINCINNATI – Protech Home Medical reported revenue of $22.8 million for the first quarter of fiscal year 2021, a 32% increase compared to the same period in 2020. 

Adjusted EBITDA was $5.1 million vs. $3.3 million, a 53% increase. 

“The momentum across the business continues to be robust as evidenced by our first quarter financial and operating results, and I am pleased to saw that we are seeing similar strong trends into our second quarter,” said CEO and Chairman Greg Crawford. 

Protech reported respiratory resupply set ups and/or deliveries increased to 34,996 in the first quarter of FY21 compared to 13,439 for the same period in 2020, a 160% increase. It reported 51,836 vs. 39,070 unique patients served. 

Crawford highlighted that recurring revenue for the trailing twelve months at the end of the first quarter of fiscal year 2021 was 75% of total revenue. 

“We anticipate a further uptick with a full quarter of contribution from SleepWell,” he said. “This strong recurring revenue platform provides us further stability and consistency as it relates to our growth outlook and is a direct result of the infrastructure we have developed.” 

Protech is still expected to list its common shares on the NASDAQ within the first half of 2021.


To comment on this post, please log in to your account or set up an account now.